Proseek Bio
Proseek Bio is a clinical diagnostics company advancing multi-biomarker blood tests for women’s health, starting with ovarian cancer. Its precision glycoproteomics platform detects multiple glycoform biomarkers in a single test, improving diagnostic accuracy and reducing false alarms. The platform runs on existing clinical mass spectrometers, requiring no new reagents or equipment for pathology labs.
- Healthcare Technology
- Biotechnology
Funding
Founders
Founder details are not available yet.
Product
Problem
Most tumor markers ignore the sugars (glycans) attached to proteins, which reduces diagnostic accuracy and contributes to false alarms. Women with endometriosis face a 10x higher risk of ovarian cancer, and women overall receive diagnoses 4 years later than men across many conditions, delaying critical treatment.
Solution
Proseek Bio provides a precision glycoproteomics platform that detects multiple glycoform biomarkers simultaneously in a single blood test, improving diagnostic accuracy for ovarian cancer. The platform runs on standard clinical mass spectrometers, requiring no new reagents or equipment, which facilitates easy adoption by pathology labs. Tests are licensed from QIMR Berghofer, validated through peer-reviewed studies with leading universities and scientific agencies, and built to meet global regulatory standards. The workflow supports the full journey from research and development to clinical testing on one platform, reducing delays and bottlenecks in bringing diagnostics to patients.
Target Audience
Primary customers include pathology laboratories seeking validated, scalable diagnostics, as well as general practitioners and specialists who need faster, clearer answers for early ovarian cancer detection.
Features
- Multi-biomarker detection of glycoform variants in a single blood test, improving accuracy beyond conventional tumor markers
- Glycoproteomics platform that analyzes sugar modifications on proteins, a differentiating technical approach
- Runs on existing clinical mass spectrometers, compatible with standard lab workflows
- Tests licensed from QIMR Berghofer and validated through peer-reviewed studies
- Built to meet global regulatory standards for clinical diagnostics